Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-087752
Filing Date
2016-01-04
Accepted
2016-01-04 16:11:14
Documents
1
Period of Report
2015-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10586
  Complete submission text file 0001209191-16-087752.txt   12026
Mailing Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ATARA BIOTHERAPEUTICS, INC. 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Ciechanover Isaac E. (Reporting) CIK: 0001612096 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36548 | Film No.: 161318215